Topcon (7732) Q1 2026 earnings summary

Executive summary

• Q1 FY2025 consolidated net sales declined 5.7% year-over-year to ¥48.5B, with operating income turning negative at -¥0.5B due to weak demand in Positioning Business despite growth in Eye Care Business.

• Loss attributable to owners of parent widened to -¥2.1B from -¥1.0B year-over-year.

• Comprehensive income dropped to -¥1.6B from ¥5.0B year-over-year.

• Company will be delisted following a tender offer and MBO; no full-year forecast provided.

Financial highlights

• Net sales fell to ¥48.5B from ¥51.4B year-over-year; gross profit dropped 7% to ¥25.8B.

• Operating income decreased from ¥0.7B to -¥0.5B; net income worsened from -¥1.0B to -¥2.1B.

• Extraordinary losses totaled ¥1.5B, including a ¥1.3B loss from a money transfer scam at a foreign subsidiary.

• Ordinary loss expanded to -¥0.8B from -¥0.4B year-over-year.

• Basic earnings per share fell to -¥19.48 from -¥9.02 year-over-year.

Segment performance

• Positioning Business sales dropped 10% year-over-year to ¥30.5B; operating income fell 19% to ¥1.5B due to sluggish IT Construction and Agriculture demand.

• Eye Care Business sales rose 2% to ¥17.9B, with operating income improving to ¥0.1B, driven by strong North American performance and growth investments.

• Other segment sales ¥117M, segment profit -¥0.8B.

• Overseas sales accounted for 82.4% of total, down from 85.1% year-over-year.